Dengue Diagnostics

Dengue Diagnostics Tech Transfer and Pandemic Preparedness

Building an ecosystem and establishing Product-Development-Partnership (PDP) funding platforms for developing a robust diagnostics and therapeutics pipeline in the Global South.

Project

This pilot project is focused on making MyLiSA a regional hub for pandemic preparedness in Malaysia and regional. The pilot project is a dengue diagnostic tech transfer. The focus of the initiative is the technology transfer of a validated dengue diagnostic test from a biotech company Sansure Biotech to MyLiSA’s low-volume manufacturing facility at the University of Malaya (UM). By enabling local production and adaptation of high-quality diagnostic tools, the project aims to reduce reliance on imported diagnostics and strengthen Malaysia’s ability to respond swiftly to outbreaks.

Our approach combines technology transfer, capacity building, and multi-stakeholder collaboration. The project team works closely with Sansure Biotech to adapt diagnostic protocols and quality systems for local use. MyLiSA is equipped to handle low-volume manufacturing and test kit assembly at UM, while regulatory, clinical, and implementation pathways are supported through partnerships with public health institutions and hospitals.

A broader engagement strategy includes training programs, workshops, and knowledge exchange platforms to ensure technology absorption and long-term sustainability. The pilot will serve as a blueprint for expanding diagnostic preparedness to other diseases such as influenza, COVID-19 variants, and other emerging threats.

Initiatives

Dengue RT-PCR Diagnostic Transfer: Adaptation and local production of Sansure’s test at MyLiSA
Clinical Validation Study: Multi-site study across UMMC and MOH hospitals for performance evaluation
Workforce Training: Skill development in diagnostic manufacturing, regulatory processes, and quality assurance